Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 22, 2021

View Archived Issues

Uncovering the roles of enteric glial cells in intestinal homeostasis, immunity and tissue repair

ARID1A is a marker of endometriosis progression

BUD13 identified as candidate gene in specific language impairment

Targeting GSDMD-mediated pyroptosis as therapeutic strategy for endometriosis

Fujifilm patents HDAC6 inhibitors

Merck & Co. divulges new coagulation factor XIa inhibitors

Takeda Pharmaceutical synthesizes new somatostatin SST4 receptor agonists

Enyo Pharma presents ICD inducers

Researchers identify new GPR52 agonists

GLI1 inhibition as a novel strategy for the treatment of uterine leiomyosarcoma

Loxo Oncology details discovery and testing of PI3Kalpha and FGFR inhibitors

SLFN11 predicts treatment response to TAS-1553 in AML

Purnovate selects PNV-5030 as lead compound in pain program

Cedilla announces lead programs focused on conditional inhibition of TEAD and CDK2

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Atreca and Gates MRI enter licensing agreement on MAM-01 for malaria

Splice variant in DEGS1 leads to hypomyelinating leukodystrophy-like phenotype

Regeneron ADC REGN3124-PBD prolongs survival in mice with intracranial glioblastoma tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...